Acacia senegal gum exudate offers protection against cyclophosphamide- induced urinary bladder cytotoxicity

Oxidative Medicine and Cellular Longevity

Volumn 2, Issue 4, 2009, Pages 207-213

  Al Yahya, Abdulaziz A ^a   Al Majed, Abdulhakeem A ^a   Gado, Ali M ^a   Daba, Mohammad H ^a   Al Shabanah, Othman A ^a   El Azab, Adel S ^a   Abd Allah, Adel R A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Acrolein; Bladder inflammation; Cyclophosphamide; Gum arabic; Lipid peroxidation; Oxidative stress

Indexed keywords

ACETYLCHOLINE; CYCLOPHOSPHAMIDE; DRINKING WATER; GLUTATHIONE; GUM ARABIC; MALONALDEHYDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ACACIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CONTRACTION; BLADDER INJURY; CELL PROTECTION; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYSTITIS; CYTOTOXICITY; DESQUAMATION; DRUG EFFECT; EDEMA; EROSION; EXTRAVASATION; HISTOLOGY; IN VITRO STUDY; ISOLATED ORGAN; LAMINA PROPRIA; LIPID PEROXIDATION; MALE; MICROSCOPY; NONHUMAN; ORGAN WEIGHT; PETECHIA; RAT; TISSUE HOMOGENATE; TISSUE STRUCTURE; UROTHELIUM;

ACETYLCHOLINE; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; CYSTITIS; EDEMA; GLUTATHIONE; GUM ARABIC; INFLAMMATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; RATS; URINARY BLADDER;

ACACIA; ACACIA SENEGAL; RATTUS;

EID: 77953468282     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.2.4.8878     Document Type: Article

References (49)

1. Moore MJ. Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet 1991; 20:194-208.
2. Hengstler JG, Hengst A, Fuchs J, Tanner B, Phol J, Oesch F. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1. Mutat Res 1997; 373:215-23.
3. Levy L, Harris R. Effect of N-acetylcysteine on some aspects of cyclophosphamide induced toxicity and immuno-suppression. Biochem Pharmacol 1977; 26:1015-20.
4. Cox Pj. Cyclophosphamide-cystitis identification of acrolein as the causative agent. Biochem Pharmacol 1977; 28:2045-9.
5. Austin HA, Klippel JH, Balow JE, Le Riche NGH, Steinberg AD, Plotz PH, Decker JL. Therapy of lupus nephrits-controlled trial of prednisone and cytotoxic drugs. N Eng J Med 1986; 314:614-9.
6. Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide toxicity characterizing and avoiding problem. Drugs 1991; 42:781-95.
7. Takamoto S, Sakura N, Namera A, Yashiki M. Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 806:59-63.
8. Fraiser LH, Kehrer JP. Murine strain differences in metabolism and bladder toxicity of cyclophosphamide. Toxicology 1992; 7:255-72.
9. Philips FS, Sternberg SS, Cronin AP, Vidal PM. Cyclophosphamide and urinary bladder toxicity. Cancer Res 1961; 21:1577-89.
10. Alfieri AB, Cubeddu LX. Nitric oxide and NK1-Tachkinin receptors in cyclophosphamide-induced cystitis in rats. J Pharmacol Exper Ther 2000; 295:824-9.
11. Das UB, Mallick M, Debnath JM, Ghosh D. Protective effect of ascorbic acid on cyclophosphamide-induced testicular gametogenic and androgenic disorders in male rats. Asian J Androl 2002; 4:201-7.
12. Gurtoo HL, Hipkens JH, Sharma SD. Role of glutathione in the metabolism dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res 1981; 41:3584-91.
13. Lee FYF. Glutathione diminishes the anti-tumor activity of 4-hydroperoxycyclophosphamide by stabilizing its spontaneous breakdown to alkylating metabolites. Br J Cancer 1991; 63:45-50.
14. Qing WG, Powell KL, MacLeod MC. Kinetics of the reaction of a potential chemopreventive agent, 2,6-dithiopurine and its major metabolite, 2,6-dithiouric acid, with multiple classes of electrophilic toxicants. Chem Res Toxicol 1996; 9:1298-304.
15. Datta K, Chin A, Ahmed T, Qing WG, Powell KL, Simhambhatla P, et al. Mixed effects of 2,6-dithiopurine against cyclophosphamide mediated bladder and lung toxicity in mice. Toxicology 1998; 125:1-11.
16. 1 receptor-mediated motor responses in normal or inflamed rat urinary bladder in vivo. Regulatory Peptides 1999; 80:41-7.
17. Brock N, Pohl J. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazophosphorine cytostatics. IARC Sci Publ 1986; 78:269-79.
18. Navarova J, Ujhazy E, Dubovicky M. Protective effect of the antioxidant stobadine against cyclophosphamide and irradiation induced oxidative stress. Gen Physiol Biophys 1999; 18:112-9.
19. Abd-Allah AR, Gado AM, Al-Majed AA, Al-Yahya AA, Al-Shabanah OA. Protective effect of Taurine against cyclophosphamide induced urinary bladder toxicity in rats. Clin Exper Pharmacol Physiol 2005; 31:167-72.
20. Al-Majed AA, Mostafa AM, Al-Rikabi AC, Al-Shabanah OA. Protective effects of oral arabic gum administration on gentamicin-induced nephrotoxicity in rats. Pharmacol Res 2002; 46:445-51.
21. Al-Majed AA, Abd-Allah ARA, Al-Rikabi AC, Al-Shabanah OA, Mostafa AM. Effect of oral administration of Arabic gum on Cisplatin-induced nephrotoxicity in rats. J Biochem Mol Toxicol 2003; 17:146-53.
22. Al-Majed AA. Oral Arabic gum administration prevents carbon tetrachloride-induced hepatotoxicity in mice: A possible mechanism of protection. Res Commun Pharmacol Toxicol 2003; 8:35-48.
23. Ali BH, Ziada A, Blunden G. Biological effects of Gum Arabic: A review of some recent research. Food Chem Toxicol 2009; 47:1-8.
24. Mahendran T, Williams PA, Phillips GO, Al-Assaf S, Baldwin TC. New insights into the structural characteristics of the arabinogalactan-protein (AGP) fraction of gum arabic. J Agric Food Chem 2008; 56:9269-76.
25. Gamal El-din AM, Mostafa AM, Al-Shabanah OA, Al-Bekairi AM, Nagi MN. Protective effect of arabic gum against acetaminophen-induced hepatotoxicity in mice. Pharmacol Res 2003; 48:631-5.
26. Rehman KU, Codipilly CN, Wapnir RA. Modulation of small intestinal nitric oxide synthase by gum arabic. Exp Biol Med 2004; 229:895-901.
27. Ali BH. Does gum arabic have an antioxidant action in rat kidney? Ren Fail 2004; 26:1-3.
28. Abd-Allah AR, Al-Majed AA, Mostafa AM, Al-Shabanah OA, Din AG, Nagi MN. Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection. J Biochem Mol Toxicol 2002; 16:254-9.
29. Ramu K, Fraiser LH, Mamiya B, Ahmed T, Kehrer JP. Acrolein mercapturates: synthesis, characterization and assessment of their role in the bladder toxicity of cyclophosphamide. Chem Res Toxicol 1995; 8:515-24.
30. Ramu K, Perry CS, Ahmed T, Pakenham G, Kehrer JP. Studies on the basis for the toxicity of acrolein mercapturates. Toxicol Appl Pharmacol 1996; 140:487-98.
31. Arumugam N, Sivakumar V, Thanislass J, Pillai KS, Devaraj SN, Devaraj H. Acute pulmonary toxicity of acrolein in rats-underlying mechanism. Toxicol Lett 1999; 104:189-94.
32. Arumugam N, Thanislass J, Ragunath K, Niranjali Devaraj S, Devaraj H. Acroleininduced toxicicy-defective mitochondrial function as a possible mechanism. Arch Environ Contam Toxicol 1999; 36:373-6.
33. Adams JD Jr, Klaidman LK. Acrolein-induced oxygen radical formation. Free Radic Biol Med 1993; 15:187-93.
34. Bullock G, Tang C, Tourkina E, Ibrado AM, Lutzky J, Huang Y, et al. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-induced programmed cell death of apoptosis in human myeloid leukemia cells. Exp Hematol 1993; 21:1640-7.
35. Hengstler JG, Hengst A, Fuchs J, Tanner B, Phol J, Oesch F. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1. Mutat Res 1997; 373:215-23.
36. Inci K, Ismailoglu UB, Sahin A, Sungur A, Sahin-Erdemli I. The effect of inflammation on rat urinary bladder-dependent relaxation in coaxial bioassay system. Naunyn Schmiedebergs Arch Pharmacol 2003; 367:457-552.
37. Manesh C, Kuttan G. Alleviation of cyclophosphamide-induced urotoxicity by naturally occurring sulphur compounds. J Exp Clin Cancer Res 2002; 21:509-17.
38. Oter S, Korkmaz A, Oztas E, Yildirim I, Topal T, Bikgic H. Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats. Ureol Res 2004; 32:185-9.
39. Rehman K, Wingertzahn MA, Harper RG, Wapnir RA. Proabsorptive action of gum Arabic: regulation of nitric oxide metabolism in the basolateral potassium channel of the small intestine. J Ped Gast Nut 2001; 32:529-33.
40. O'Dell BL, Morris ER, Pickett EE, Hogan AG. Diet composition and mineral balance in guinea pigs. J Nutrition 1957; 63:65-77.
41. Shue GM, Douglass CD, Friedman I. Nutritional studies of complex carbohydrates. Federation proceedings 1962; 21:91-5.
42. Johnson JB, Newman LH. Intravenous injection of acacia. Arch Intern Med 1945; 76:167-71.
43. Booth AN, Elvehjem CA, Hart EB. The importance of bulk in nutrition of guinea pig. J Nutr 1949; 37:263-8.
44. Bachmann E, Zbinden G. Biochemical effects of chronically administered suspended agents on mitochondrial metabolism and hepatic mixed function oxidase in rats, mice and hamster. Arch Toxicol Suppl 1978; 1:183-7.
45. Xu X, Malave A. Protective effect of Berberine on cyclophosphamide hemorrhagic cystitis in rats. Pharmacol Toxicol 2001; 88:232-7.
46. Ohkawa H, Ohish N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid. Anal Biochem 1979; 95:351-8.
47. Ellman GL. Tissue sulfahydryl groups. Arch Biochem Biophys 1959; 82:70-7.
48. Ozawa H, Chancellor MB, Jung SY, Yokoyama T, Fraser MO, Yu Y, et al. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis. J Urol 1999; 162:2211-6.
49. Mostafa AM, Nagi MN, Al-Shabanah OA, El-Kashef HA. Effect of amino-guanidine and melatonin on the response of isolated urinary bladder to acetylcholine in normal and diabetic rats. Med Sci Res 2000; 28:33-7.